Page 6 - Mike Hencke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biogen (BIIB) Q4 2022 Earnings Call Transcript

BIIB earnings call for the period ending December 31, 2022.

United statesMike mcdonnellTim andersonEvan seigermanSalveen richter goldman sachsPriya singhalMike henckeMichael yeeChristopher viehbacherBrian abrahamsSalveen richterChris schott jpmorganSamsung bioepisChris schottMichael yee jefferiesColin bristow

Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression

Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKathryn ritzingerCharles weissmannWalter gilbertHeinz schallerLaura gaultPriya singhalMike henckeJack coxHelen rubinsteinKenneth murrayHead of researchCommittee opinion noDrug administrationRegulatory sciences at biogen

LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN

/PRNewswire/ Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,.

United kingdomUnited statesHaruo naitoCharles weissmannWalter gilbertHeinz schallerLibby holmanChristophera viehbacherMike henckeNatacha gassenbachKenneth murrayPrnewswire eisai co ltdInvestor relations departmentNational institute onBiogen incPublic relations department

Biogen (BIIB) Announces Lecanemab Receives Priority Review Status in Japan

Biogen (BIIB) Announces Lecanemab Receives Priority Review Status in Japan
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mike henckeNatacha gassenbachCharles weissmannWalter gilbertHeinz schallerLibby holmanKenneth murrayInvestor relations departmentNational institute onBiogen incEisai co ltd corporate conceptPublic relations departmentNational institutes of healthDrug administrationEisai incWashington university school of medicine

Biogen Inc : Lecanemab Receives Priority Review Status in Japan

TOKYO and CAMBRIDGE, Mass., Jan. 29, 2023 (GLOBE NEWSWIRE) Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts

United kingdomUnited statesHaruo naitoCharles weissmannWalter gilbertHeinz schallerLibby holmanChristophera viehbacherMike henckeNatacha gassenbachKenneth murrayInvestor relations departmentNational institute onBiogen incPublic relations departmentNational institutes of health